Target intelligence / Profile preview

NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 2, mitochondrial (NDUFB2)

Target
NDUFB2
Molecular classification
Enzyme (specifically an accessory subunit of mitochondrial respiratory chain Complex I), Component of the mitochondrial respiratory chain complex
01

Overview

NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 2, mitochondrial (NDUFB2), is an accessory subunit of Complex I (NADH:ubiquinone oxidoreductase) in the mitochondrial respiratory chain. It does not participate directly in the catalytic activity of electron transfer but is important for complex stability and function. Complex I is responsible for the transfer of electrons from NADH to ubiquinone (coenzyme Q10), an essential step in oxidative phosphorylation and ATP production. NDUFB2 helps anchor the complex within the inner mitochondrial membrane and may play a role in modulating complex I assembly or stability. Alterations in NDUFB2 expression or function have been associated with several pathological conditions, including mitochondrial diseases (such as Leigh disease), oxidative stress in cardiac injury, and venous thromboembolism in the context of liver disease. Note: - No direct drugs are known to target NDUFB2 specifically; any interaction would be as part of general Complex I inhibitors (such as rotenone), but these are not clinically used due to toxicity. - NDUFB2 is considered a molecular target for research and may serve as a biomarker in certain oxidative and mitochondrial pathologies, but not a current direct therapeutic target.

Other names
CI-AGGGAGGGNDUB2NADH:ubiquinone oxidoreductase subunit B2complex I-AGGGNADH-ubiquinone oxidoreductase AGGG subunitNADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2, 8kDa
02

Biological functions

Mitochondrial electron transportOxidative phosphorylationCellular energy metabolism
03

Disease associations

Mitochondrial diseaseLeigh diseaseCardiovascular disease (e.g., ischemia/reperfusion injury)Venous thromboembolism, especially associated with liver cirrhosis
04

Safety considerations

Dysfunction may contribute to mitochondrial dysfunction and resulting diseases; no established direct safety concerns as a drug target
05

Biomarkers

Possible biomarker for oxidative stress injury in the heartPossible marker in venous thromboembolism with liver disease

Beyond the preview

Go deeper on NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 2, mitochondrial (NDUFB2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 2, mitochondrial (NDUFB2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call